Grabel, Michael http://orcid.org/0000-0002-7141-2016
Merola, Aristide
Article History
Received: 15 September 2022
Accepted: 9 November 2022
First Online: 15 November 2022
Change Date: 13 January 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1007/s10072-024-07321-1
Declarations
:
: Michael Grabel: nothing to declare. Aristide Merola: received speaker honoraria from Abbott and Boston Scientific, advisory board compensation from Abbott, Abbvie, Boston Scientific, and Lundbeck, and compensation as Chief Editor from Frontiers in Neurology Experimental Therapeutics.
: This study did not require approval from an ethics committee.
: Informed consent was not obtained because the data comes from papers that already had consent to publish.